VisionSys AI Inc ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $149K0.0% YoYTTM through 31 Dec 2025
Net Income $245.8M0.0% YoYTTM through 30 Jun 2025
Free Cash Flow -$37.8MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 22.1% |
| EBITDA Margin | -57.7% |
| Operating Margin | -3,836.9% |
| Net Margin | 164,963.8% |
Balance Sheet Health
Debt / Equity0.00x
Current Ratio14.44x
Net Debt-$7.9Mnet cash position
Cash & Equivalents$7.9M
Quality Metrics
Altman Z-Score-11.60
Piotroski F-Score4 / 9
FCF Margin-25,371.1%
Multi-Year Trend
RevenueFY2025: $149K
Diluted EPSFY2025: $1.27
Dividend
No dividend
Capital Allocation
R&D Spend$2.6M
Capex Intensity7,318.8%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Brain-Computer Interface (BCI) Technologies | $144.5K | View detailsThe company is focused exclusively on developing brain-computer interface (BCI) technologies through its PRC subsidiary Beijing Wangwen, targeting medical, healthcare, and general wellness applications. |
Financials converted at 6.9961.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.